Comparison of Repaglinide versus Other Oral Agents in Patients with Type 2 Diabetes Mellitus Receiving Insulin Therapy: A Systematic Review and Meta-Analysis

A Olanrewaju; Devada Singh-Franco; W Marsh; Alexandra Perez; Alexandra Perez Rivera

Comparison of Repaglinide versus Other Oral Agents in Patients with Type 2 Diabetes Mellitus Receiving Insulin Therapy: A Systematic Review and Meta-Analysis

A Olanrewaju
, Devada Singh-Franco
, W Marsh
, Alexandra Perez
, Alexandra Perez Rivera

Department of Pharmacy Practice

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - Sep 6 2022

Keywords

insulin therapy
oral agents
patients
repaglinide
type 2 diabetes mellitus

Disciplines

Medicine and Health Sciences
Pharmacy and Pharmaceutical Sciences

Cite this

@conference{bfe11d2c2e914b039da1eedc11969c08,

title = "Comparison of Repaglinide versus Other Oral Agents in Patients with Type 2 Diabetes Mellitus Receiving Insulin Therapy: A Systematic Review and Meta-Analysis",

keywords = "insulin therapy, oral agents, patients, repaglinide, type 2 diabetes mellitus",

author = "A Olanrewaju and Devada Singh-Franco and W Marsh and Alexandra Perez and \{Perez Rivera\}, Alexandra",

year = "2022",

month = sep,

day = "6",

language = "American English",

}

TY - CONF

T1 - Comparison of Repaglinide versus Other Oral Agents in Patients with Type 2 Diabetes Mellitus Receiving Insulin Therapy: A Systematic Review and Meta-Analysis

AU - Olanrewaju, A

AU - Singh-Franco, Devada

AU - Marsh, W

AU - Perez, Alexandra

AU - Perez Rivera, Alexandra

PY - 2022/9/6

Y1 - 2022/9/6

KW - insulin therapy

KW - oral agents

KW - patients

KW - repaglinide

KW - type 2 diabetes mellitus

UR - https://nsuworks.nova.edu/hpd_corx_facpres/680

M3 - Presentation

ER -

Comparison of Repaglinide versus Other Oral Agents in Patients with Type 2 Diabetes Mellitus Receiving Insulin Therapy: A Systematic Review and Meta-Analysis

Keywords

Disciplines

Other files and links

Cite this